Video

Dr. Zillioux discusses same-day discharge for FPMRS procedures

Author(s):

Urology Times staff

"Same-day discharge is safe and feasible across a broad spectrum of FPMRS cases," says Jacqueline Zillioux, MD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Jacqueline Zillioux, MD, discusses the recent Neurourology & Urodynamics paper, “Same-day discharge across FPMRS surgical cases is safe and feasible: A 10-year single-surgeon experience.” Zillioux is a urology FPMRS fellow at Cleveland Clinic.

      Related Videos
      Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
      Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
      Prostate cancer screening: Expert weighs in after Biden's diagnosis
      Prostate cancer screening: Expert weighs in after Biden's diagnosis
      Sarah Razavi, MD, answers a question during a Zoom video interview
      Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
      Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
      Study results affirm effectiveness of evolving prostate cancer therapies
      Laura Davis, MD, on link between microplastics and bladder cancer
      Laura Davis, MD, on link between microplastics and bladder cancer
      Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
      Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
      Considerations for patient follow-up after onabotA administration
      Considerations for patient follow-up after onabotA administration
      Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
      Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
      Administering onabotA: Improving patient comfort and easing anxiety
      Administering onabotA: Improving patient comfort and easing anxiety
      Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
      Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access
      Related Content
      Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
      May 16th 2025

      Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

      Melissa Kaufman, MD, PhD, FACS Hannah Clarke
      The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.
      Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
      April 29th 2025

      Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025

      Amy M. Pearlman, MD Rachel Rubin, MD
      Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.
      Hospital waiting room with reception counter at medical facility | Image Credit: © visoot - stock.adobe.com
      April 5th 2025

      Vaginal prolapse repair and sling surgery significantly reduce UUI

      Christina M. Mezes, DO Catherine A. Matthews, MD
      "The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.
      Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
      April 28th 2025

      Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause

      Melissa Kaufman, MD, PhD, FACS
      In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
      FDA grants marketing authorization to at-home diagnostic test for STIs
      March 28th 2025

      FDA grants marketing authorization to at-home diagnostic test for STIs

      Hannah Clarke
      The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.
      Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
      March 25th 2025

      Expert discusses unique mechanism of action of UTI treatment gepotidacin

      Ryan Haumschild, PharmD, MS, MBA, CPEL
      "I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.
      © 2025 MJH Life Sciences

      All rights reserved.